On March 19, according to the New York Post, US Senator Chuck Schumer called on the FDA to investigate a popular Chinese-made e-cigarette and "prepare to ban it from the market". He believes that this e-cigarette directly appeals to children and teenagers through social media, and circumvents US advertising laws.
According to a search on the official website of the US Congress by 2FIRSTS, Schumer is a senior federal senator affiliated with the Democratic Party and is the current Senate Majority Leader representing the state of New York.
Criticism has been levied against ELFBAR for marketing through social media platforms.
On March 19th, he released a statement stating that ELFBAR uses flavors that are appealing to children, such as rainbow candy, peach mango, marshmallow, and vanilla ice cream. The packaging is also colorful, aimed at attracting younger customers.
In his statement, he also mentioned that although the FDA has taken significant steps to quell the use of brands such as JUUL, e-cigarettes like ELF BAR are still engaging in marketing through unconventional and illegal methods. He accused ELF BAR of utilizing influencer marketing on social media platforms such as TikTok and Instagram to promote their products.
Schumer stated in his announcement, "These tactics may circumvent FDA advertising regulations, and we must stay ahead of it.
Call for it to be banned from the market.
According to reports, in June 2022, the FDA issued a marketing ban on JUUL, which forced the company to take its products off the market in the United States. Schumer stated that ElFBAR may be worse than JUUL due to its "poor manufacturing process, risks of counterfeit products, and risks of mislabeling nicotine content".
In his statement, he added that federal regulators must use their "full authority and power to investigate and take action against ELFBAR, and be prepared to ban it from the market.
Schumer's Previous Stance
According to 2FIRSTS, Senator Schumer, along with two other senators, has introduced the Cannabis Administration and Opportunity Act (CAOA), which would remove marijuana from the Controlled Substances Act, making possession and use of marijuana no longer a crime and eliminating low-level federal marijuana convictions.
Back in August 2016, Schumer had expressed concern over the issue of "electronic cigarettes". At the time, during an interview, he had stated that "too many e-cigarette devices are ticking time bombs".
Too many e-cigarette devices are ticking time bombs," according to Schumer's office news center.
In the comments section of the Twitter post by the New York Post about this news, some netizens evaluated Schumer's behavior in this way.
Some jest that Schumer did not receive his kickback.
I guess Chuck didn't get his kickbacks" | Source: New York Post Twitter. (Note: The original statement is already in English but contains colloquial language and informal grammar. To translate to standard journalistic English, the statement is simply rephrased using formal language and proper grammar.)
Some netizens believe that he should focus on other issues.
Chuck should investigate a lot of other things! This is a distraction! | Source: New York Post Twitter.
For instance, many have raised concerns about America's true drug scourge: the fentanyl crisis.
Where is fentanyl? Chuck, have you heard of fentanyl?" | Source: New York Post Twitter
The comment with the highest number of likes suggests that Schumer has invested in other e-cigarette companies.
He must have invested in other e-cigarette companies" | Source: New York Post Twitter.
As of the deadline, the FDA has not responded to the request for a statement from Schomer.
References:
The New York Post reports that Senator Schumer has accused the Elf Bar, a colorful e-cigarette made in China, of using influencers to target children.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
